Last viewed: SNY


Prices are updated after-hours



nasdaq:SNY Sanofi

SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-1.7% 1m) (-1.0% 1y) (0.0% 2d) (-1.1% 3d) (2.9% 7d) (Infinity% volume)
Earnings Calendar:
http://www.sanofi.com
Sec Filling | Patents | 100409 employees

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

vaccine   cardiovascular   diabetes   diabetic  

add to watch list email alert is off

Price chart


% (High / Open) change chart




Press-releases


Cellectis Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D., Ph.D., to its Board of Directors
Published: 2022-06-28 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $108.84 | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
CLLS | News | $2.92 -9.03% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
RLAY | News S | $16.38 -12.27% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist


United States Human Vaccines Markets, 2018-2021 & Forecast to 2028: Approval/launches of the New Vaccines / Rising Focus on Immunization Programs / Increasing Investments and Government Support
Published: 2022-06-28 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $108.84 | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
DVAX | News | $12.18 -2.56% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist


Survey: Digital Workplaces Help Frontline Teams Look Beyond the "Big Quit"
Published: 2022-06-28 (Crawled : 15:00) - prnewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%


Hepion Pharmaceuticals Further Strengthens Board with Appointments of Accomplished Biopharmaceutical Executives, Mr. Anand Reddi and Dr. Kaouthar Lbiati
Published: 2022-06-28 (Crawled : 13:00) - contravir.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%
HEPA | News | $0.6549 -2.6% 1.13% | twitter stocktwits trandingview |
Health Technology
| | O: -1.17% H: 1.49% C: -2.99%


G1 Therapeutics Announces Addition of Jacks Lee to Board of Directors
Published: 2022-06-28 (Crawled : 12:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%
GTHX | News A | $5.19 -2.99% -0.37% | twitter stocktwits trandingview |
Health Technology
| | O: -2.37% H: 3.18% C: -3.18%

therapeutics
Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD
Published: 2022-06-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%

xenpozyme treatment for approved
Press Release: Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease
Published: 2022-06-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%

nexviadyme treatment care disease for approved potential
Sanofi Enters into a Partnering Agreement with Health2Sync
Published: 2022-06-28 (Crawled : 04:00) - prnewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%

agreement sanofi
MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published: 2022-06-28 (Crawled : 02:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%
ABBV | News | $152.49 -0.42% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 1.27% C: -0.44%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

pharma
Sanofi: Information concerning the total number of voting rights and shares – May 2022
Published: 2022-06-27 (Crawled : 21:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%


See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Last 48 Hours Insiders Buying
ALTG P 3227 | $9.29 -2.52% 0.0% | twitter stocktwits trandingview |
Distribution Services
| 01:40
SKIL P 30000 | $3.61 -6.96% 0.0% | twitter stocktwits trandingview |
Information
| 23:50
CAMP P 20000 | $4.65 -1.27% -0.43% | twitter stocktwits trandingview |
Electronic Technology
| 16:00